FR363M - New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections. - Google Patents

New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.

Info

Publication number
FR363M
FR363M FR837022A FR837022A FR363M FR 363 M FR363 M FR 363M FR 837022 A FR837022 A FR 837022A FR 837022 A FR837022 A FR 837022A FR 363 M FR363 M FR 363M
Authority
FR
France
Prior art keywords
penicillofacial
trypanosomosis
salmonellosis
infections
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837022A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR805450A external-priority patent/FR1274407A/en
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Priority to FR837022A priority Critical patent/FR363M/en
Application granted granted Critical
Publication of FR363M publication Critical patent/FR363M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/74—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals
    • C07D307/76—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by hydrazino or hydrazono or such substituted radicals having carbonic acyl radicals or their thio or nitrogen analogues directly attached to the hydrazino or hydrazono radical, e.g. semicarbazides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR837022A 1958-09-25 1960-08-29 New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections. Active FR363M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837022A FR363M (en) 1958-09-25 1960-08-29 New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US763176A US3159654A (en) 1958-09-25 1958-09-25 New series of carboxylic acid esters of 5-nitro-2-furyl alkylidene hydroxyalkyl semicbazones
FR805450A FR1274407A (en) 1959-09-18 1959-09-18 Novel Esters of the Nitrofuran Series and Method for Their Preparation
FR837022A FR363M (en) 1958-09-25 1960-08-29 New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.

Publications (1)

Publication Number Publication Date
FR363M true FR363M (en) 1961-04-04

Family

ID=25067080

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837022A Active FR363M (en) 1958-09-25 1960-08-29 New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.

Country Status (5)

Country Link
US (1) US3159654A (en)
CH (1) CH378340A (en)
ES (1) ES251886A1 (en)
FR (1) FR363M (en)
NL (1) NL6712659A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL302096A (en) * 1962-12-19
TWI371450B (en) * 2001-08-13 2012-09-01 Du Pont Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2416234A (en) * 1945-08-28 1947-02-18 Eaton Lab Inc Series of nitrofuran compounds
US2656350A (en) * 1950-05-29 1953-10-20 Eaton Lab Inc Series of nitrofuran compounds comprising substituted 5-nitro-2-furaldehyde semicarbazones

Also Published As

Publication number Publication date
ES251886A1 (en) 1960-03-01
NL6712659A (en) 1967-11-27
US3159654A (en) 1964-12-01
CH378340A (en) 1964-06-15

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
NL140186B (en) CLEAR LAYERED PRODUCT.
FR362M (en) New drug for the treatment of staphylococcal infections and salmonellosis.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
BE582173A (en) Advanced device for the treatment of threads.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR364M (en) New drug for the treatment of salmonellosis, staphylococcal disease and trichomonosis.
FR2193M (en) New drug for the treatment of infectious diseases.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR1878M (en) New polysaccharide, usable in therapy, in particular for the treatment of solid tumors.
FR3875M (en) New drug particularly suitable for the treatment of tuberculosis infections.
FR2802M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR1412M (en) New drug in particular for the treatment of bronchitis, pneumonia, heart collapse and heart failure.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR36M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.
FR1731M (en) New amino-pyrazole which can be used in therapy, in particular as a drug for the treatment of inflammatory conditions.